HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bland White Garland Syndrome

A congenital coronary vessel anomaly in which the left main CORONARY ARTERY originates from the PULMONARY ARTERY instead of from AORTA. The congenital heart defect typically results in coronary artery FISTULA; LEFT-SIDED HEART FAILURE and MITRAL VALVE INSUFFICIENCY during the first months of life.
Also Known As:
ALCAPA; ALCAPA Syndrome; Bland-White-Garland Syndrome; ALCAPA Syndromes; Syndrome, ALCAPA; Syndrome, Bland-White-Garland
Networked: 122 relevant articles (1 outcomes, 9 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Anomalous Left Coronary Artery
2. Critical Illness (Critically Ill)
3. Mitral Valve Insufficiency (Mitral Regurgitation)
4. Cardiac Sudden Death (Sudden Cardiac Arrest)
5. Pathologic Constriction (Stenosis)

Experts

1. Yan, Fuxia: 3 articles (06/2020 - 12/2018)
2. Li, Shoujun: 3 articles (05/2020 - 12/2018)
3. Alexi-Meskishvili, Vladimir: 3 articles (10/2014 - 10/2011)
4. Berger, Felix: 3 articles (10/2014 - 10/2011)
5. Gao, Yuchen: 2 articles (06/2020 - 01/2018)
6. Peng, Yong G: 2 articles (06/2020 - 01/2018)
7. Wang, Chunrong: 2 articles (06/2020 - 01/2018)
8. Wang, Jianhui: 2 articles (06/2020 - 01/2018)
9. Wang, Sudena: 2 articles (06/2020 - 01/2018)
10. Wang, Yuefu: 2 articles (06/2020 - 01/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Bland White Garland Syndrome:
1. iodofiltic acidIBA
2. Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
3. Thallium-201IBA
4. DobutamineFDA LinkGeneric
5. Anesthetics (Anesthetic Agents)IBA
6. Nicorandil (SG 75)IBA
7. Intravenous Immunoglobulins (IVIG)FDA Link
8. Radioisotopes (Radionuclides)IBA
9. Prednisone (Sone)FDA LinkGeneric
10. Platelet Factor 4IBA

Therapies and Procedures

1. Replantation
2. Therapeutics
3. Extracorporeal Membrane Oxygenation
07/01/2011 - "This study was undertaken to determine whether long-term outcomes for children supported with extracorporeal membrane oxygenation (ECMO) after ALCAPA repair differ from those in children who did not require ECMO. "
01/01/2000 - "The objective of this review was to analyze a surgical strategy for children with anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) where aortic implantation was successful without the use of extracorporeal membrane oxygenation (ECMO) or left ventricular assist device (LVAD). "
09/01/2019 - "We present the case of a 7-week-old male infant diagnosed with anomalous left coronary artery from the pulmonary artery (ALCAPA) who underwent repair by left coronary artery reimplantation, followed by an eventful postoperative period including need for venous arterial extracorporeal membrane oxygenation and mitral valve replacement due to mitral calcification and severe insufficiency. "
01/01/1994 - "Two patients with ALCAPA who developed low cardiac output and could not be weaned from cardiopulmonary bypass (CPB) after aortic reimplantation of the anomalous left coronary artery were successfully treated with a centrifugal left ventricular assist device (LVAD) and extracorporeal membrane oxygenation (ECMO). "
01/01/2009 - "We report two cases of ALCAPA from the RPA: the first case, an infant, presented in severe cardiac failure requiring preoperative extracorporeal membrane oxygenation (ECMO) for stabilization; and the second, a neonate, presented with severe aortic coarctation (CoA). "
4. Ligation
5. Coronary Artery Bypass (Coronary Artery Bypass Surgery)